-
EP4062934
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4062934
| EP4062934 - COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING ANTI-CD300C MONOCLONAL ANTIBODIES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 26.08.2022 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 29.05.2021 | Most recent event Tooltip | 27.07.2024 | Amendment by applicant | Applicant(s) | For all designated states CentricsBio, Inc. 3F, BK Tower, 28, Beobwon-ro 11-gil Songpa-gu Seoul 05836 / KR | [2022/39] | Inventor(s) | 01 /
JEON, Jaewon 134, Beopjo-ro, Yeongtong-gu Gyeonggi-do 16512 / KR | 02 /
LEE, Suin 71, Jangjahosu-gil Guri-si, Gyeonggi-do 11949 / KR | 03 /
KIM, Woochang 2317, Yeongseo-ro Chuncheon-si, Gangwon-do 24434 / KR | 04 /
KIM, Haneul 104, Pyeongnae-ro Namyangju-si, Gyeonggi-do 12226 / KR | [2022/39] | Representative(s) | Dehns 10 Old Bailey London EC4M 7NG / GB | [N/P] |
| Former [2022/39] | Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | Application number, filing date | 20891244.4 | 18.11.2020 | [2022/39] | WO2020KR16264 | Priority number, date | KR20190147496 | 18.11.2019 Original published format: KR 20190147496 | KR20200154076 | 17.11.2020 Original published format: KR 20200154076 | [2022/39] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021101244 | Date: | 27.05.2021 | Language: | KO | [2021/21] | Type: | A1 Application with search report | No.: | EP4062934 | Date: | 28.09.2022 | Language: | EN | [2022/39] | Search report(s) | International search report - published on: | KR | 27.05.2021 | (Supplementary) European search report - dispatched on: | EP | 16.02.2024 | Classification | IPC: | A61K39/395, A61K31/713, A61K45/06, A61P35/00, C07K16/28 | [2022/39] | CPC: |
A61P35/00 (EP);
A61K45/06 (EP);
C07K16/2803 (EP);
C07K16/2818 (EP);
A61K2039/505 (EP);
A61K2039/507 (EP);
C07K2317/33 (EP);
C07K2317/73 (EP);
C07K2317/76 (EP);
C07K2317/92 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/39] | Title | German: | ZUSAMMENSETZUNG ZUR VORBEUGUNG ODER BEHANDLUNG VON KREBS MIT MONOKLONALEN ANTI-CD300C-ANTIKÖRPERN | [2022/39] | English: | COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING ANTI-CD300C MONOCLONAL ANTIBODIES | [2022/39] | French: | COMPOSITION POUR LA PRÉVENTION OU LE TRAITEMENT DU CANCER, COMPRENANT DES ANTICORPS MONOCLONAUX ANTI-CD300C | [2022/39] | Entry into regional phase | 18.05.2022 | Translation filed | 18.05.2022 | National basic fee paid | 18.05.2022 | Search fee paid | 18.05.2022 | Designation fee(s) paid | 18.05.2022 | Examination fee paid | Examination procedure | 18.05.2022 | Examination requested [2022/39] | 25.07.2024 | Amendment by applicant (claims and/or description) | 25.07.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 23.11.2022 | Renewal fee patent year 03 | 24.11.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]EP3808375 (CENTRICSBIO INC [KR]); | International search | [A]US2016194631 (YUAN JUNYING [US], et al); | [A]WO2018094460 (DENDROCYTE BIOTECH PTY LTD [AU]); | [PX]KR20190136949 (CENTRICS BIO [KR]); | by applicant | KR20180099557 |